World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
96
Citations
32239
World Ranking
864
National Ranking
28

Medicine

D-Index
96
Citations
32383
World Ranking
9709
National Ranking
377

Jan W. Drijfhout publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jan W. Drijfhout sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 330 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jan W. Drijfhout D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jan W. Drijfhout sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 96 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jan W. Drijfhout is affiliated with Leiden University Medical Center in the Netherlands. Their research spans several interconnected fields, primarily focusing on Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology.

The scientist's work emphasizes subfields such as Molecular Biology, Microbiology, Immunology, Radiology, Nuclear Medicine and Imaging, and Oncology. Within these realms, Drijfhout explores topics including Antimicrobial Peptides and Activities, Biochemical and Structural Characterization, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, Peptidase Inhibition and Analysis, as well as Rheumatoid Arthritis Research and Therapies.

Several recent papers illustrate the breadth of Drijfhout's research contributions:

  • Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications, 2020, Annals of the Rheumatic Diseases
  • A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection, 2022, Nature Communications
  • CalcAMP: A New Machine Learning Model for the Accurate Prediction of Antimicrobial Activity of Peptides, 2023, Antibiotics
  • Thrombocidin-1-derived antimicrobial peptide TC19 combats superficial multi-drug resistant bacterial wound infections, 2020, Biochimica et Biophysica Acta (BBA) - Biomembranes
  • Ototopical drops containing a novel antibacterial synthetic peptide: Safety and efficacy in adults with chronic suppurative otitis media, 2020, PLoS ONE

Drijfhout has collaborated frequently with several researchers, including Robert A. Cordfunke, Peter H. Nibbering, Peter A. van Veelen, Natasja Dolezal, and Miriam E. van Gent.

The scientist's publications have appeared often in venues such as Antibiotics, bioRxiv (Cold Spring Harbor Laboratory), Proceedings of the National Academy of Sciences, Biomolecules, and Analytical Chemistry. These journals reflect a focus on antimicrobial research, biochemical characterization, and molecular biology.

Best Publications

  • Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

    Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

  • Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

    M. C. W. Feltkamp;H. L. Smits;M. P. M. Vierboom;R. P. Minnaar

  • The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides

    Willemijn Vader;Yvonne Kooy;Peter van Veelen;Arnoud de Ru

  • The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor

    G. Sandra Tjabringa;Jamil Aarbiou;Dennis K. Ninaber;Jan Wouter Drijfhout

  • Cross-presentation by intercellular peptide transfer through gap junctions

    Joost Neijssen;Carla Herberts;Jan Wouter Drijfhout;Eric Reits

  • Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.

    W. A. Erik Marijt;Mirjam H. M. Heemskerk;Freke M. Kloosterboer;Els Goulmy

  • Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease

    L. Willemijn Vader;Arnoud de Ru;Yvonne van der Wal;Yvonne M.C. Kooy

  • Identification of a Graft-versus-Host Disease-associated human minor Histocompatibility antigen.

    Joke M. M. den Haan;Nicholas E. Sherman;Els Blokland;Eric Huczko

  • The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms

    Anna de Breij;Martijn Riool;Robert A. Cordfunke;Nermina Malanovic

  • High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical Cancer

    Sytse J. Piersma;Ekaterina S. Jordanova;Mariëtte I.E. van Poelgeest;Kitty M.C. Kwappenberg

  • Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.

    Marij J P Welters;Gemma G Kenter;Sytse J Piersma;Annelies P G Vloon

  • MANNOSE RECEPTOR-MEDIATED UPTAKE OF ANTIGENS STRONGLY ENHANCES HLA CLASS II-RESTRICTED ANTIGEN PRESENTATION BY CULTURED DENDRITIC CELLS

    M. C. A. A. Tan;A. M. Mommaas;J. W. Drijfhout;R. Jordens

  • CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

    Ania Skowera;Richard J. Ellis;Ruben Varela-Calviño;Sefina Arif

  • The HLA-A^*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

    Leslie Meadows;Wei Wang;Joke M.M den Haan;Els Blokland

  • Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity

    Gemma G Kenter;Marij J P Welters;A Rob P M Valentijn;Margriet J G Lowik

  • Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

    Diane van der Woude;Solbritt Rantapää-Dahlqvist;Andreea Ioan-Facsinay;Carla Onnekink

  • Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I.

    Eric Reits;Alexander Griekspoor;Joost Neijssen;Tom Groothuis

  • Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6

    Annemieke de Jong;Mariëtte I. E. van Poelgeest;Jeanette M. van der Hulst;Jan Wouter Drijfhout

  • Efficient Identification of Novel HLA-A * 0201-presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen PRAME by Proteasome-mediated Digestion Analysis

    Jan H. Kessler;Nico J. Beekman;Sandra A. Bres-Vloemans;Pauline Verdijk

  • A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

    Eric Reits;Joost Neijssen;Carla Herberts;Willemien Benckhuijsen

Frequent Co-Authors

Frits Koning
Frits Koning Leiden University Medical Center
Peter A. van Veelen
Peter A. van Veelen Leiden University Medical Center
Cornelis J. M. Melief
Cornelis J. M. Melief ISA Pharmaceuticals (Netherlands)
Sjoerd H. van der Burg
Sjoerd H. van der Burg Leiden University Medical Center
Bart O. Roep
Bart O. Roep Leiden University Medical Center
Rienk Offringa
Rienk Offringa German Cancer Research Center
Kees L. M. C. Franken
Kees L. M. C. Franken Leiden University Medical Center
Ferry Ossendorp
Ferry Ossendorp Leiden University Medical Center
Peter H. Nibbering
Peter H. Nibbering Leiden University Medical Center
Gemma G. Kenter
Gemma G. Kenter Vrije Universiteit Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to various healthcare and research careers that often require complementary nursing or allied health qualifications. Many students pursuing immunology also consider accelerated nursing pathways to enhance their clinical skills and career prospects.

For example, students with a non-nursing background might explore the best online BSN programs for non nurses, which provide a direct transition into nursing through flexible online formats. These programs are designed to accommodate learners coming from diverse academic fields.

Additionally, those interested in advanced practice can look into an accelerated FNP program to become a Family Nurse Practitioner, combining immunology knowledge with patient care expertise.

For quicker entry points into nursing, options like the easiest ABSN program to get into offer accelerated Bachelor of Science in Nursing routes, while the best easiest LPN programs to get into provide a fast track to Licensed Practical Nurse certification. These pathways support diverse career goals in immunology-related healthcare roles.

Best Scientists Citing Jan W. Drijfhout

Trending Scientists

Recently Published Articles